Question:
What J code should I report for intravenous temozolomide? New Jersey Subscriber
Answer:
HCPCS doesn't currently offer a specific code for temozolomide, so you should report J9999 (
Not otherwise classified, antineoplastic drugs).
Stay tuned:
Temozolomide, sold as Temodar, had a spot in the April 2009 HCPCS Public Meeting agenda (
www.cms.hhs.gov/MedHCPCSGenInfo/Downloads/DrugBiologicalsandRadiopharmaceuticals-Agenda.pdf).
CMS's preliminary decision was to create a J code for "Injection, Temozolomide, 1mg."
Who needs it:
Oncologists use temozolomide for adult patients with glioblastoma multiforme (coded as a malignant neoplasm based on site) and refractory anaplastic astrocytoma (also coded as malignant neoplasm by site).